Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones. (Q45953850)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Amir Khammari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Nathalie Labarrière

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jean-Michel Nguyen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marie-Christine Pandolfino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Anne C Knol

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Gaëlle Quéreux

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Soraya Saiagh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Anabelle Brocard

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Francine Jotereau

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Brigitte Dreno

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

25 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

2835-2842

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

Treatment of metastatic malignant melanoma

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Detection of intracellular cytokines by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.144

7 January 2021

Identifiers

DOI

10.1038/JID.2009.144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19554023%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 February 2020

1048433096

0 references

1 reference